We are live on ! Find out more
SRTA

Strata Critical Medical Inc

99 hedge funds and large institutions have $156M invested in Strata Critical Medical Inc in 2022 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 22 increasing their positions, 35 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 8

3% more funds holding

Funds holding: 9699 (+3)

9% less call options, than puts

Call options by funds: $1.63M | Put options by funds: $1.8M

1.14% less ownership

Funds ownership: 55.36%54.22% (-1.1%)

20% less capital invested

Capital invested by funds: $195M → $156M (-$38.6M)

37% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 35

Holders
99
Holders Change
+3
Holders Change %
+3.13%
% of All Funds
1.71%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
22
Reduced
35
Closed
8
Calls
$1.63M
Puts
$1.8M
Net Calls
-$165K
Net Calls Change
-$469K
Name Holding Trade Value Shares
Change
Change in
Stake
HVCM
1
HG Vora Capital Management
New York
$31.7M
AIM
2
ARK Investment Management
Florida
$29.6M -$2.64M -514,945 -7%
Sumitomo Mitsui Trust Group
3
Sumitomo Mitsui Trust Group
Japan
$19.6M -$276K -53,754 -1%
NAMA
4
Nikko Asset Management Americas
New York
$19.5M -$276K -53,754 -1%
BlackRock
5
BlackRock
New York
$14.9M -$28.8K -5,604 -0.2%
Vanguard Group
6
Vanguard Group
Pennsylvania
$11.3M +$258K +50,255 +2%
State Street
7
State Street
Massachusetts
$4.93M -$3.11M -605,220 -33%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$3.87M +$49.7K +9,679 +1%
EMG
9
ETF Managers Group
New Jersey
$2.76M -$271K -52,814 -7%
BGIM
10
Brandywine Global Investment Management
Pennsylvania
$2.13M +$2.71M +527,900 New
Northern Trust
11
Northern Trust
Illinois
$1.82M -$57.8K -11,246 -2%
AWS
12
AJ Wealth Strategies
New York
$1.5M
N
13
Nuveen
North Carolina
$834K -$27.3K -5,314 -3%
QOP
14
Quinn Opportunity Partners
Virginia
$688K -$115K -22,341 -12%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$682K +$80.2K +15,617 +10%
IP
16
Intellectus Partners
California
$667K +$17.2K +3,350 +2%
Charles Schwab
17
Charles Schwab
California
$568K -$776 -151 -0.1%
DRS
18
Deane Retirement Strategies
Louisiana
$535K +$671K +130,717 +6,703%
Citadel Advisors
19
Citadel Advisors
Florida
$512K -$77.3K -15,054 -11%
SAM
20
Stansberry Asset Management
Texas
$410K -$12K -2,334 -2%
Swiss National Bank
21
Swiss National Bank
Switzerland
$404K
AIM
22
Allen Investment Management
New York
$403K
UBS Group
23
UBS Group
Switzerland
$399K +$96.9K +18,870 +24%
RhumbLine Advisers
24
RhumbLine Advisers
Massachusetts
$328K -$17K -3,302 -4%
ICM
25
Ionic Capital Management
New York
$319K +$302K +58,726 +286%

SRTA Hedge Fund Activity: Q3 2022 in Review

99 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Strata Critical Medical Inc (SRTA) for Q3 2022, worth a combined $156M — down 20% from $195M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new SRTA positions and 8 closed out — a net gain of 4 holders — while 22 added to existing stakes and 35 trimmed.

The largest buyer was Brandywine Global Investment Management, opening a new position worth an estimated $2.71M. The largest seller was State Street, cutting an estimated $3.11M.

  • 99 institutional investors held Strata Critical Medical Inc (SRTA) as of Q3 2022, up from 96 in Q2 2022.
  • Funds reported $156M of Strata Critical Medical Inc stock for Q3 2022, down 20% quarter-over-quarter.
  • 12 funds opened new Strata Critical Medical Inc positions in Q3 2022 and 8 closed out, a net change of +4 holders.
  • The largest Strata Critical Medical Inc buyer in Q3 2022 was Brandywine Global Investment Management, an estimated $2.71M added.
  • The largest Strata Critical Medical Inc seller in Q3 2022 was State Street, an estimated $3.11M sold.

Based on aggregated 13F filings for Q3 2022.